Is cognitive decline measurable in preclinical Alzheimer's disease?

Sandra Weintraub; Christopher Randolph; Lisa Bain; James A. Hendrix; Maria C. Carrillo

doi:10.1016/j.jalz.2017.02.002

Is cognitive decline measurable in preclinical Alzheimer's disease?

Sandra Weintraub, Christopher Randolph, Lisa Bain, James A. Hendrix^*, Maria C. Carrillo

^*Corresponding author for this work

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Short survey › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	322-323
Number of pages	2
Journal	Alzheimer's and Dementia
Volume	13
Issue number	3
DOIs	https://doi.org/10.1016/j.jalz.2017.02.002
State	Published - Mar 1 2017

ASJC Scopus subject areas

Epidemiology
Health Policy
Developmental Neuroscience
Clinical Neurology
Geriatrics and Gerontology
Cellular and Molecular Neuroscience
Psychiatry and Mental health

Access to Document

10.1016/j.jalz.2017.02.002

Cite this

@article{918698af22c948e3886d344a22ebcaaa,

title = "Is cognitive decline measurable in preclinical Alzheimer's disease?",

author = "Sandra Weintraub and Christopher Randolph and Lisa Bain and Hendrix, {James A.} and Carrillo, {Maria C.}",

year = "2017",

month = mar,

day = "1",

doi = "10.1016/j.jalz.2017.02.002",

language = "English (US)",

volume = "13",

pages = "322--323",

journal = "Alzheimer's and Dementia",

issn = "1552-5260",